myelofibrosis

[키워드] Activation admitted to ICU approach approved CAR-T caused COVID-19 COVID-19 mortality COVID-19 patient CRS cytokine cytokine release deleterious effect dendritic cells evaluated events ferritin fibrosis graft-versus-host-disease hematologic hematological high mortality HLH Hospitalization hyperinflammation ICU IL-6 immune-cell Immunotherapy impacted IMPROVE Italy Jak JAK1 JAK2 janus kinase limit lymphocyte Macrophage management Migration molecular molecular mechanism multi-organ failure myelofibrosis outbreak outcome overcome pathogenic Patient Proinflammatory cytokine reducing Respiratory failure ruxolitinib SARS-CoV-2 selective Signaling solid tumor storm syndrome tissue damage TNFα treated Treatment turn virus
[DOI] 10.3389/fonc.2020.599502 PMC 바로가기 [Article Type] Oncology